Senseonics Stock Forecast, Price & News

-0.27 (-6.82 %)
(As of 06/15/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume57.75 million shs
Average Volume44.00 million shs
Market Capitalization$1.58 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SENS News and Ratings via Email

Sign-up to receive the latest news and ratings for Senseonics and its competitors with MarketBeat's FREE daily newsletter.

Senseonics logo

About Senseonics

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to 90 and 180 days. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company was founded in 1996 and is headquartered in Germantown, Maryland.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.72 out of 5 stars

Medical Sector

1316th out of 2,100 stocks

Process Control Instruments Industry

17th out of 25 stocks

Analyst Opinion: 0.9Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Senseonics (NYSEAMERICAN:SENS) Frequently Asked Questions

Is Senseonics a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last twelve months. There are currently 2 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Senseonics stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SENS, but not buy additional shares or sell existing shares.
View analyst ratings for Senseonics
or view top-rated stocks.

What stocks does MarketBeat like better than Senseonics?

Wall Street analysts have given Senseonics a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Senseonics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Senseonics' next earnings date?

Senseonics is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021.
View our earnings forecast for Senseonics

How were Senseonics' earnings last quarter?

Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) posted its quarterly earnings data on Thursday, May, 13th. The company reported ($0.68) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by $0.63.
View Senseonics' earnings history

What guidance has Senseonics issued on next quarter's earnings?

Senseonics issued an update on its FY 2021 earnings guidance on Tuesday, June, 8th. The company provided earnings per share guidance of $- for the period. The company issued revenue guidance of $12 million-15 million, compared to the consensus revenue estimate of $12.85 million.

What price target have analysts set for SENS?

5 brokerages have issued 12 month price objectives for Senseonics' stock. Their forecasts range from $1.00 to $3.00. On average, they expect Senseonics' stock price to reach $2.17 in the next twelve months. This suggests that the stock has a possible downside of 41.3%.
View analysts' price targets for Senseonics
or view top-rated stocks among Wall Street analysts.

Who are Senseonics' key executives?

Senseonics' management team includes the following people:
  • Dr. Timothy T. Goodnow, Pres, CEO & Director (Age 59, Pay $1.05M)
  • Dr. Mukul Jain, Chief Operating Officer (Age 48, Pay $619.15k)
  • Dr. Francine Ratner Kaufman, Chief Medical Officer & Director (Age 70, Pay $739.49k)
  • Mr. Nick B. Tressler M.B.A., CFO, Sec. & Treasurer (Age 48)
  • Mr. Kenneth L. Horton, Gen. Counsel & Corp. Devel. Advisor (Age 54)

Who are some of Senseonics' key competitors?

What other stocks do shareholders of Senseonics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include VirnetX (VHC), Advanced Micro Devices (AMD), Micron Technology (MU), Nabriva Therapeutics (NBRV), Sorrento Therapeutics (SRNE), Amarin (AMRN), Tandem Diabetes Care (TNDM), CytoDyn (CYDY), TransEnterix (TRXC) and TherapeuticsMD (TXMD).

What is Senseonics' stock symbol?

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Who are Senseonics' major shareholders?

Senseonics' stock is owned by many different institutional and retail investors. Top institutional shareholders include Masters Capital Management LLC (2.19%), BlackRock Inc. (1.32%), Gilder Gagnon Howe & Co. LLC (1.04%), Geode Capital Management LLC (0.55%), Renaissance Technologies LLC (0.42%) and Morgan Stanley (0.38%). Company insiders that own Senseonics stock include Douglas A Roeder, Douglas S Prince, Francine Kaufman, Mukul Jain, Stephen P Defalco and Timothy T Goodnow.
View institutional ownership trends for Senseonics

Which institutional investors are selling Senseonics stock?

SENS stock was sold by a variety of institutional investors in the last quarter, including Gilder Gagnon Howe & Co. LLC, Daiwa Securities Group Inc., Rockefeller Capital Management L.P., Price T Rowe Associates Inc. MD, Perkins Capital Management Inc., Johnson & Johnson Innovation JJDC Inc., Dfpg Investments LLC, and Global Retirement Partners LLC. Company insiders that have sold Senseonics company stock in the last year include Douglas A Roeder, Douglas S Prince, Francine Kaufman, Mukul Jain, Stephen P Defalco, and Timothy T Goodnow.
View insider buying and selling activity for Senseonics
or view top insider-selling stocks.

Which institutional investors are buying Senseonics stock?

SENS stock was bought by a variety of institutional investors in the last quarter, including Masters Capital Management LLC, BlackRock Inc., Morgan Stanley, Geode Capital Management LLC, HRT Financial LP, Renaissance Technologies LLC, Northern Trust Corp, and Goldman Sachs Group Inc..
View insider buying and selling activity for Senseonics
or or view top insider-buying stocks.

How do I buy shares of Senseonics?

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Senseonics' stock price today?

One share of SENS stock can currently be purchased for approximately $3.69.

How much money does Senseonics make?

Senseonics has a market capitalization of $1.58 billion and generates $4.95 million in revenue each year. The company earns $-175,170,000.00 in net income (profit) each year or ($0.42) on an earnings per share basis.

How many employees does Senseonics have?

Senseonics employs 82 workers across the globe.

What is Senseonics' official website?

The official website for Senseonics is www.senseonics.com.

Where are Senseonics' headquarters?

Senseonics is headquartered at 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States.

How can I contact Senseonics?

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at (301) 515-7260.

This page was last updated on 6/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.